Accessibility Menu
 
Hutchmed (China) logo

Hutchmed (China)

(LSE) HCM

Current Price$195.00
Market Cap$170.11B
Since IPO (2006)+678%
5 Year-46%
1 Year-16%
1 Month-13%

Hutchmed (China) Financials at a Glance

Market Cap

$170.11B

Revenue (TTM)

$602.20M

Net Income (TTM)

$466.88M

EPS (TTM)

$40.36

P/E Ratio

4.83

Dividend

$0.00

Beta (Volatility)

-0.30 (Low)

Price

$195.00

Volume

9

Open

$191.00

Previous Close

$195.00

Daily Range

$191.00 - $195.00

52-Week Range

$190.98 - $292.00

HCM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hutchmed (China)

Industry

Pharmaceuticals

Employees

1,796

CEO

Chig Fung Cheng

Headquarters

Hong Kong, HK

HCM Financials

Key Financial Metrics (TTM)

Gross Margin

19%

Operating Margin

-3%

Net Income Margin

1%

Return on Equity

46%

Return on Capital

-1%

Return on Assets

26%

Earnings Yield

20.70%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$170.11B

Shares Outstanding

872.34M

Volume

9

Avg. Volume

36.04K

Financials (TTM)

Gross Profit

$212.22M

Operating Income

$54.59M

EBITDA

$41.28M

Operating Cash Flow

$64.67M

Capital Expenditure

$14.15M

Free Cash Flow

$78.82M

Cash & ST Invst.

$1.37B

Total Debt

$97.76M

Hutchmed (China) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$138.84M

-9.2%

Gross Profit

$55.05M

-12.3%

Gross Margin

39.65%

N/A

Market Cap

$170.11B

N/A

Market Cap/Employee

$93.93M

N/A

Employees

1,811

N/A

Net Income

$227.48M

+1663.3%

EBITDA

$1.30M

+112.2%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$1.27B

+69.5%

Accounts Receivable

$147.63M

-5.1%

Inventory

$41.13M

-18.4%

Long Term Debt

$70.04M

+10.3%

Short Term Debt

$27.85M

+5.9%

Return on Assets

26.29%

N/A

Return on Invested Capital

-0.81%

N/A

Free Cash Flow

$41.08M

-64.5%

Operating Cash Flow

$36.45M

-83.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HIK.LHikma Pharmaceuticals PLC
$1427.00+0.67%
GNS.LGenus plc
$2330.00+0.43%
ONT.LOxford Nanopore Technologies plc
$114.50+1.24%
AGY.LAllergy Therapeutics plc
$9.60-11.52%

Trending Stocks

Symbol / CompanyPricePrice Chg
RXTRackspace Technology
$5.49+0.56%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$15.62+0.08%
IRENIren
$61.20+0.08%
TQQQProShares Trust - ProShares UltraPro Qqq
$76.28+0.07%

Questions About HCM

What is the current price of Hutchmed (China)?

Hutchmed (China) is trading at GBX 195.00 per share.

What is the 52-week range for Hutchmed (China)?

Over the past 52 weeks, Hutchmed (China) has traded between GBX 190.98 and GBX 292.00.

How much debt does Hutchmed (China) have?

As of the most recent reporting period, Hutchmed (China) reported total debt of $72.78M.

How much cash does Hutchmed (China) have on hand?

Hutchmed (China) reported $53.03M in cash and cash equivalents in its most recent financial results.

What is Hutchmed (China)’s dividend yield?

Hutchmed (China) does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.